PREVALENCE OF ALIMENTARY OBESITY IN PATIENTS WITH GOUT
DOI:
https://doi.org/10.11603/2411-1597.2018.1.9097Abstract
The article highlights features of alimentary obesity in patients with gout and relevance of research of it.
References
Dzhanashiya P. H. Yavlyaetsya li giperurikemiya komponentom metabolicheskogo sindroma? / P. H. Dzhanashiya, V. A. Dibenko // Rossiyskiy kardiologicheskiy zhurnal. – 2002. – # 1. – S. 15–17.
Dolzhenko, M. N. Lipidnyiy distress-sindrom ili novoe – eto horosho zabyitoe staroe? / M. N. Dolzhenko, Mistetstvo lIkuvannya. – 2006. – # 7. – S. 28–31.
Arev A. L. Podagra / A. L. Arev. – SPb. : SPbMAPO, 2009. – 109 s.
Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 2003; 88:2399—2403
Disbioz: sovremennyie vozmozhnosti profilaktiki i lecheniya / V. M. Bondarenko, V. F. Uchaykin, A. O. Murashova [i dr.] – M., 1995. – 68 s.
Arromdee E., Michet C.J., Crowson C.S. Epidemiology of Gout: Is the Incidence Rising? J. Rheumatol. – 2005. № 29: 2403–2406.
Trifiro G., Morabito P., Cavagna L. et al. Epidemiology of gout and hyperuricemia in Italy during the years 2005–2009: a nationwide population-based study Ann. Rheum. Dis. – 2013. – 72. – P. 694–700
Protsenko H. O. Monitorynh tryvaloho likuvannia khvorykh na podahru / H. O. Protsenko, N. S. Boichuk // Ukr. revmatol. zhurn. – 2007. – № 4. – S. 30–33.
Protsenko, H. O. Osoblyvosti perebihu podahry u zhinok / H. O. Protsenko // Visnyk naukovykh doslidzhen. – Ternopil : Ukrmedknyha. – 2008. – № 3. – S. 18– Kazimirko V. K. Revmatologiya / V. K. Kazimirko, V. N. Kovalenko – uchebnoe posobie dlya vrachey v voprosah i otvetah. K., 2009. – 626 s.
Dalbeth N., So A. Hyperuricaemia and gout: state of the art and future perspectives // Ann. Rheum. Dis. – 2010. – 69(10). – Р. 1738–1743.
Nasonova V. A. Sovremennoe uchenie o podagre. V pomosch praktikuyuschemu vrachu / V. A. Nasonova, V. G. Barskova. Zdorov’ya UkraYini. –2005. – S. 129
Wallace K.L., Riedel A.A., Joseph-Ridge N. et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adult in a managed care population. J. Rheumatol. -2004. № 31: 1582–1587.
Stamp, L. K., Chapman, P. T. Gout and its comorbidities: implications for therapy. Rheumatology. – 2013. № 52(1), 34–44.
Prevalence of gout and hyperuricemia in the US general population:
the National Health and Nutrition Examination Survey 2007–2008
Arthritis Rheum. – 2011. – 63(10). – Р. 3136–3141
Annemans L., Spaepen E. et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005 // Ann. Reum. Dis. – 2008. – 67. – Р. 960–966.
Cavagna L., Trifirò G., Caporali R. еt al. Prevalence and incidence of gout in Italy. Analysis of a primary care database // Ann. Rheum. Dis. – 2012. – 71(13). – Р. 721.
Moroz H.Z.Podahra: suchasni pidkhody do diahnostyky ta likuvannia/Moroz H.Z./ Therapia. –2010. –7–8(49).
Svintsitskyi A. S. (2006) Revmatychni khvoroby ta syndromy / A. S. Svintsitskyi, O. B. Yaremenko, O. H. Puzanova, N. I. Khomchenkova // K. : Knyha-plius, 2006. – 680 s.
Sinyachenko, T. V. Myagkova, G. A. Ignatenko // Vrachebnaya praktika. – 2006. – # 2. – S. 50–55.
Dalbeth, N., Stamp, L. Hyperuricaemia and gout: time for a new staging system? Annals of the rheumatic diseases, annrheumdis – 2014.